Literature DB >> 11734765

High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children.

G A Syrogiannopoulos1, I N Grivea, F Fitoussi, C Doit, G D Katopodis, E Bingen, N G Beratis.   

Abstract

BACKGROUND: Macrolide resistance among Streptococcus pyogenes strains is increasing in many European countries. Greece was not considered a country with high prevalence of macrolide-resistant S. pyogenes strains, and until now the genetic mechanism of resistance was unknown.
METHODS: During the 25-month period from December, 1998, to December, 2000, pharyngeal cultures for S. pyogenes were performed on 743 Greek children with the clinical diagnosis of pharyngitis. The children were 1 to 16 years old (median age, 7 years) and were living in Central and Southern Greece. S. pyogenes isolates were tested for their susceptibility to erythromycin, clarithromycin, azithromycin, clindamycin, penicillin G, amoxicillin/clavulanate and cefprozil. The erythromycin-resistant isolates were further studied for their genetic mechanism of resistance by means of PCR.
RESULTS: Of a total of 275 S. pyogenes isolates recovered, 105 (38%) were erythromycin-resistant (MIC > or = 1 microgram/ml) [corrected], with 54, 45 and 1% of them carrying mef(A), erm(A) [subclass erm(TR)] and erm(B) gene, respectively. The prevalence of erythromycin-resistant strains was 29 and 42% during the time periods December, 1998, to December, 1999, and January, 2000, to December, 2000, respectively. All erythromycin-resistant isolates were also resistant to clarithromycin and azithromycin. The isolates carrying the erm(A) gene were inducibly resistant to clindamycin. The 275 S. pyogenes isolates had ceprozil MICs < or = 0.032 microgram/ml.
CONCLUSIONS: The current high (38%) prevalence of erythromycin-resistant S. pyogenes in Central and Southern Greece requires continuous surveillance and careful antibiotic policy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734765     DOI: 10.1097/00006454-200109000-00008

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

Review 1.  Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E).

Authors:  Corné H W Klaassen; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Changes in Macrolide Resistance Among Group A Streptococci in Serbia and Clonal Evolution of Resistant Isolates.

Authors:  Ina Gajic; Vera Mijac; Lazar Ranin; Edita Grego; Dusan Kekic; Boris Jegorovic; Aleksandra Smitran; Suncica Popovic; Natasa Opavski
Journal:  Microb Drug Resist       Date:  2018-03-20       Impact factor: 3.431

3.  Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants.

Authors:  P Littauer; D A Caugant; M Sangvik; E A Høiby; A Sundsfjord; G S Simonsen
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

Review 4.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

5.  Identification of group A streptococcal emm types commonly associated with invasive infections and antimicrobial resistance by the use of multiplex PCR and high-resolution melting analysis.

Authors:  P Bidet; S Liguori; C Plainvert; S Bonacorsi; C Courroux; C d'Humières; C Poyart; A Efstratiou; E Bingen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-20       Impact factor: 3.267

6.  Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain.

Authors:  C García-Rey; L Aguilar; F Baquero; J Casal; J E Martín
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 7.  Streptococcus pyogenes biofilms-formation, biology, and clinical relevance.

Authors:  Tomas Fiedler; Thomas Köller; Bernd Kreikemeyer
Journal:  Front Cell Infect Microbiol       Date:  2015-02-11       Impact factor: 5.293

8.  Genetic commonality of macrolide-resistant group A beta hemolytic streptococcus pharyngeal strains.

Authors:  Angela L Myers; Mary Anne Jackson; Rangaraj Selvarangan; Richard V Goering; Christopher Harrison
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-12-01       Impact factor: 3.944

9.  Contribution of exogenous genetic elements to the group A Streptococcus metagenome.

Authors:  Stephen B Beres; James M Musser
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

10.  Throat culture positivity rate and antibiotic susceptibility pattern of beta-hemolytic streptococci in children on secondary prophylaxis for rheumatic heart disease.

Authors:  Nigus Zegeye; Daniel Asrat; Yimtubezinash Woldeamanuel; Abebe Habte; Etsegenet Gedlu; Tone Tønjum; Abraham Aseffa
Journal:  BMC Infect Dis       Date:  2016-09-23       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.